Teva Pharmaceutical Industries (TEVA) Debt Ratio (2016 - 2025)
Historic Debt Ratio for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to 0.41.
- Teva Pharmaceutical Industries' Debt Ratio fell 879.2% to 0.41 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.41, marking a year-over-year decrease of 879.2%. This contributed to the annual value of 0.41 for FY2025, which is 879.2% down from last year.
- According to the latest figures from Q4 2025, Teva Pharmaceutical Industries' Debt Ratio is 0.41, which was down 879.2% from 0.42 recorded in Q3 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Debt Ratio registered a high of 0.51 during Q2 2021, and its lowest value of 0.41 during Q4 2025.
- Its 5-year average for Debt Ratio is 0.47, with a median of 0.48 in 2023.
- In the last 5 years, Teva Pharmaceutical Industries' Debt Ratio surged by 807.32% in 2021 and then tumbled by 879.2% in 2025.
- Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Debt Ratio stood at 0.48 in 2021, then decreased by 0.3% to 0.48 in 2022, then fell by 5.36% to 0.46 in 2023, then dropped by 0.87% to 0.45 in 2024, then dropped by 8.79% to 0.41 in 2025.
- Its last three reported values are 0.41 in Q4 2025, 0.42 for Q3 2025, and 0.43 during Q2 2025.